BCLI BRAINSTORM CELL THERAPEUTICS INC Management Changes 8-K Filing 2023 - Amendment and Separation Agreement Brainstorm Cell Therapeutics Inc. has entered into an amendment with Dr. Stacy Lindborg, appointing her as Co-Chief Executive Officer with a base salary of $500,000 and eligibility for bonuses and equity grants. They have also entered into a separation agreement with Dr. Ralph Kern, providing him with a payment of $250,000, non-restricted shares of common stock, and a prorated annual bonus.Get access to all SEC 8-K filings of the BRAINSTORM CELL THERAPEUTICS INC